Celldex Therapeutics
CLDX
CLDX
150 hedge funds and large institutions have $2.28B invested in Celldex Therapeutics in 2013 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 46 increasing their positions, 50 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 50
Holders
150
Holding in Top 10
1
Calls
$73.3M
Puts
$32.4M
Top Buyers
| 1 | +$258M | |
| 2 | +$46.1M | |
| 3 | +$33.5M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$23.9M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$23.8M |
Top Sellers
| 1 | -$88.9M | |
| 2 | -$50.5M | |
| 3 | -$25.3M | |
| 4 |
PCA
Private Capital Advisors
Darien,
Connecticut
|
-$23M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$21.9M |